Jonathan H. Ward

Jonathan H. Ward works in Heart Failure / Cardiomyopathy affiliated with Novartis (Switzerland).

Jonathan H. Ward, PharmD, is affiliated with Novartis Pharmaceuticals Corporation in East Hanover, NJ, USA, and has contributed to multiple studies on sacubitril/valsartan in heart failure. His research includes analyses from trials such as PARAGLIDE-HF, PARAGON-HF, and PROVE-HF. He has past associations with Massachusetts General Hospital.